These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


115 related items for PubMed ID: 12199980

  • 1. [Effects of statins on angiogenesis and vasculogenesis].
    Llevadot J, Asahara T.
    Rev Esp Cardiol; 2002 Aug; 55(8):838-44. PubMed ID: 12199980
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway.
    Dimmeler S, Aicher A, Vasa M, Mildner-Rihm C, Adler K, Tiemann M, Rütten H, Fichtlscherer S, Martin H, Zeiher AM.
    J Clin Invest; 2001 Aug; 108(3):391-7. PubMed ID: 11489932
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells.
    Asahara T, Takahashi T, Masuda H, Kalka C, Chen D, Iwaguro H, Inai Y, Silver M, Isner JM.
    EMBO J; 1999 Jul 15; 18(14):3964-72. PubMed ID: 10406801
    [Abstract] [Full Text] [Related]

  • 7. Interleukin-18/interleukin-18 binding protein signaling modulates ischemia-induced neovascularization in mice hindlimb.
    Mallat Z, Silvestre JS, Le Ricousse-Roussanne S, Lecomte-Raclet L, Corbaz A, Clergue M, Duriez M, Barateau V, Akira S, Tedgui A, Tobelem G, Chvatchko Y, Lévy BI.
    Circ Res; 2002 Sep 06; 91(5):441-8. PubMed ID: 12215494
    [Abstract] [Full Text] [Related]

  • 8. HGF/NK4 inhibited VEGF-induced angiogenesis in in vitro cultured endothelial cells and in vivo rabbit model.
    Nakabayashi M, Morishita R, Nakagami H, Kuba K, Matsumoto K, Nakamura T, Tano Y, Kaneda Y.
    Diabetologia; 2003 Jan 06; 46(1):115-23. PubMed ID: 12637990
    [Abstract] [Full Text] [Related]

  • 9. Blockade of EphA receptor tyrosine kinase activation inhibits vascular endothelial cell growth factor-induced angiogenesis.
    Cheng N, Brantley DM, Liu H, Lin Q, Enriquez M, Gale N, Yancopoulos G, Cerretti DP, Daniel TO, Chen J.
    Mol Cancer Res; 2002 Nov 06; 1(1):2-11. PubMed ID: 12496364
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Identification of a peptide blocking vascular endothelial growth factor (VEGF)-mediated angiogenesis.
    Binétruy-Tournaire R, Demangel C, Malavaud B, Vassy R, Rouyre S, Kraemer M, Plouët J, Derbin C, Perret G, Mazié JC.
    EMBO J; 2000 Apr 03; 19(7):1525-33. PubMed ID: 10747021
    [Abstract] [Full Text] [Related]

  • 12. Divergence of angiogenic and vascular permeability signaling by VEGF: inhibition of protein kinase C suppresses VEGF-induced angiogenesis, but promotes VEGF-induced, NO-dependent vascular permeability.
    Spyridopoulos I, Luedemann C, Chen D, Kearney M, Chen D, Murohara T, Principe N, Isner JM, Losordo DW.
    Arterioscler Thromb Vasc Biol; 2002 Jun 01; 22(6):901-6. PubMed ID: 12067896
    [Abstract] [Full Text] [Related]

  • 13. Vascular endothelial growth factor (VEGF) receptor-2 antagonists inhibit VEGF- and basic fibroblast growth factor-induced angiogenesis in vivo and in vitro.
    Tille JC, Wood J, Mandriota SJ, Schnell C, Ferrari S, Mestan J, Zhu Z, Witte L, Pepper MS.
    J Pharmacol Exp Ther; 2001 Dec 01; 299(3):1073-85. PubMed ID: 11714897
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Participation of the phosphatidylinositol-3-kinase/Akt/endothelial-nitric-oxide synthase signaling in the processes of angiogenesis and vascular remodeling].
    Morales M.
    Nefrologia; 2002 Dec 01; 22 Suppl 5():13-6. PubMed ID: 12107910
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Differential role of bFGF and VEGF for vasculogenesis.
    Kazemi S, Wenzel D, Kolossov E, Lenka N, Raible A, Sasse P, Hescheler J, Addicks K, Fleischmann BK, Bloch W.
    Cell Physiol Biochem; 2002 Dec 01; 12(2-3):55-62. PubMed ID: 12077550
    [Abstract] [Full Text] [Related]

  • 19. Role of Raf in vascular protection from distinct apoptotic stimuli.
    Alavi A, Hood JD, Frausto R, Stupack DG, Cheresh DA.
    Science; 2003 Jul 04; 301(5629):94-6. PubMed ID: 12843393
    [Abstract] [Full Text] [Related]

  • 20. [Vascular endothelial growth factor and nitric oxide].
    Liu YQ, Zhou AR.
    Sheng Li Ke Xue Jin Zhan; 2000 Jan 04; 31(1):69-71. PubMed ID: 12532773
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.